STOCK TITAN

Atossa Therapeutics (ATOS) Stock News, Jun-Aug 2023

ATOS NASDAQ

Atossa Therapeutics, Inc. develops clinical-stage medicines for oncology and other areas of unmet medical need. Its recurring news centers on (Z)-endoxifen, the company's lead product candidate, including breast cancer research, mammographic breast density data, and expansion into rare disease indications such as Duchenne muscular dystrophy and McCune-Albright Syndrome.

Company updates also cover FDA orphan and rare pediatric disease designations, clinical and preclinical data presentations, peer-reviewed publications, intellectual property developments, leadership additions, financial results, and capital-allocation commentary tied to Atossa's development strategy.

Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-8.29%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.88%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.54%
Tags
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.48%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.30%
Tags
none
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.84%
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.50%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
22.51%
Tags
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
8.50%
Tags
buybacks
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.56%
Tags
none

FAQ

What is the current stock price of Atossa Therapeutics (ATOS)?

Atossa Therapeutics (ATOS) last closed at $1.96.

What is the market cap of Atossa Therapeutics (ATOS)?

The market cap of Atossa Therapeutics (ATOS) is approximately $19.6M.